Product Information
KML29 is an amide compound that acts as a cannabinoid receptor agonist. It has been shown to be neuroprotective in in vitro experiments with cultured neurons and in vivo studies with rats injected with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to induce Parkinson's disease. KML29 also inhibits neuronal death induced by the fatty acid, arachidonic acid, and exhibits anti-cancer activity in a mouse model of prostate cancer. KML29 has been shown to have an effective dose at 1 mg/kg for striatal dopamine release and locomotor activity. The drug also binds to the GABAA receptor and shows efficacy against anxiety, depression, and seizures.
Chemical properties
Technical inquiry about: 3D-FFC42442 KML29
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
